Showing results (1211-1220 of 1,376) with videos related to

Sort By:
Pageof 138
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Investigating the oxidative stress-vascular brain injury axis in mild cognitive impairment of the Alzheimer's typeFlavie E Detcheverry, Sneha Senthil, Winnie L K Motue, et al.
Journal of Toxicologic Pathology|May 6, 2022
Testicular alterations in cryptorchid/orchiopexic rats chronically exposed to acrylamide or di-butyl-phthalateThania R R Lima, Nathália P Souza, Ana P Ferragut Cardoso, et al.
Cancer Causes & Control : CCC|June 26, 2017
Coffee consumption and risk of renal cell carcinomaSamuel O Antwi, Jeanette E Eckel-Passow, Nancy D Diehl, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2019
Spatiotemporal coupling of attosecond pulsesHampus Wikmark, Chen Guo, Jan Vogelsang, et al.
Annals of Clinical and Translational Neurology|March 10, 2015
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trialsVissia Viglietta, David Miller, Amit Bar-Or, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 10, 2019
A Combined Experimental and Theoretical Study of the Versatile Reactivity of an Oxocerium(IV) Complex: Concerted Versus Reductive AdditionLudovic Castro, Yat-Ming So, Chang-Woo Cho, et al.
Molecular Genetics and Metabolism|December 29, 2009
Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York StateGeorgianne L Arnold, Carlos A Saavedra-Matiz, Patricia A Galvin-Parton, et al.
Molecular Genetics and Metabolism|October 22, 2003
Improved growth and nutrition status in children with methylmalonic or propionic acidemia fed an elemental medical foodSteven Yannicelli, Phyllis B Acosta, Antonio Velazquez, et al.
Brain : a Journal of Neurology|February 1, 2022
How patients with multiple sclerosis acquire disabilityFred D Lublin, Dieter A Häring, Habib Ganjgahi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 5, 2022
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 yearsBruce Ac Cree, Douglas L Arnold, Robert J Fox, et al.
Pageof 138